Literature DB >> 2961585

The effect of opioids on rat plasma atrial natriuretic peptide.

A M Vollmar1, R M Arendt, R Schulz.   

Abstract

The effect of multiple opioid receptor agonists on plasma immunoreactive atrial natriuretic factor (IR-ANF) was studied in conscious non-hydrated rats. We found that mu-opioid receptor agonists, given subcutaneously, increased plasma IR-ANF, while kappa-receptor agonists did not alter the plasma levels of IR-ANF. The mu-agonist fentanyl (0.05 mg/kg) caused a 10-fold increase in the concentration of IR-ANF, maximal levels being reached within 5-10 min. U 50,488-H and ethylketocyclazocine (EKC), both selective kappa-receptor ligands, were ineffective in this respect. The effect of fentanyl upon plasma IR-ANF was completely abolished by pretreatment with the narcotic antagonist naltrexone, proving opioid receptor specificity of the fentanyl effect. The quaternary antagonist N-methylnaltrexone (1 mg/kg) failed to block the fentanyl-induced increase of ANF, suggesting that opiates bring about their action on ANF via a central mechanism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2961585     DOI: 10.1016/0014-2999(87)90455-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Renal effects of TAPP, a highly selective mu-opioid agonist.

Authors:  J Gutkowska; P W Schiller
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

2.  Endocrine responses to total intravenous anesthesia with droperidol, fentanyl, and ketamine in cardiac patients.

Authors:  Kazuyoshi Hirota; Shigeharu Wakayama; Kazuho Sugihara; Tsuyoshi Kudo; Tetsuhiro Sakai; Naoki Kotani; Hironori Ishihara; Akitomo Matsuki
Journal:  J Anesth       Date:  1995-09       Impact factor: 2.078

3.  Altered regulation of natriuretic peptides in the rat heart by prenatal exposure to morphine.

Authors:  S Ernest; M Jankowski; S Mukaddam-Daher; J Cusson; J Gutkowska
Journal:  J Physiol       Date:  1998-02-01       Impact factor: 5.182

4.  Thyrotropin-releasing hormone increases plasma atrial natriuretic peptide levels in human.

Authors:  O Sergev; K Rácz; I Varga; R Kiss; L Fütö; K Mohari; E Gláz
Journal:  J Endocrinol Invest       Date:  1990-09       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.